Search clinical trials for: Empagliflozin high placebo
Total 59615 results
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedType 2 Diabetes | Maturity-Onset Diabetes of the Young, Type 3Denmark
-
Hernando GomezNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Enrolling by invitationSepsis | Septic Shock | Acute Kidney Injury | MetforminUnited States
-
Themis Bioscience GmbHCompletedZika Virus InfectionAustria
-
Boehringer IngelheimCompleted
-
Cortria CorporationCompletedHyperlipidemia
-
YangjinPeking University Third HospitalNot yet recruitingPrediabetic State | Impaired Glucose Tolerance | Impaired Fasting GlucoseChina
-
National Institute of Respiratory Diseases, MexicoUnknownChronic Obstructive Pulmonary DiseaseMexico
-
AstraZenecaContract Research Organization: USA; PAREXEL Early Phase Clinical Unit Baltimore and other collaboratorsCompletedAsymptomatic HyperuricemiaUnited States
-
Duke UniversityRecruitingDiabetes Mellitus, Type 2 | Kidney Transplant; ComplicationsUnited States
-
Caroline M KistorpRigshospitalet, Denmark; Herlev and Gentofte Hospital; Danish Heart FoundationCompletedType2 Diabetes MellitusDenmark
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Australia, Greece, Italy, Norway, Poland, Portugal, Sweden
-
University Hospital, RouenAstraZenecaNot yet recruitingRenal Insufficiency, ChronicFrance
-
AstraZenecaCompleted
-
Jinnah Postgraduate Medical CentreNot yet recruitingNon-Alcoholic Fatty Liver Disease | Type2diabetesPakistan
-
McGill University Health Centre/Research Institute...RecruitingChronic Kidney Diseases | Acute Heart FailureCanada
-
University at BuffaloCompletedType 1 Diabetes MellitusUnited States
-
Universidad de CórdobaNot yet recruiting
-
Morten Hostrup, PhDRecruiting
-
Greenyn Biotechnology Co., Ltd.Taipei Medical UniversityRecruitingDiabetes | Metabolic DiseaseTaiwan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSystemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, China, Poland, Brazil, Argentina, Chile, Philippines, Australia, Colombia, Bulgaria, Mexico, Serbia, Greece, Spain, Israel, Japan, Mauritius, Moldova, Republic of, Romania, South Africa
-
Anavex Life Sciences Corp.Anavex Australia Pty Ltd.; Anavex Germany GmbH; Anavex Canada Ltd.CompletedAlzheimer DiseaseAustralia, Canada, Germany, Netherlands, United Kingdom
-
Anavex Life Sciences Corp.Anavex Germany GmbHCompleted
-
AstraZenecaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedDiabetic NephropathyRomania, Bulgaria, Hungary, Poland, Czech Republic, Slovakia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Oregon State UniversitySamaritan Health ServicesRecruitingPreDiabetes | Prediabetic State | Overweight and ObesityUnited States
-
University of PisaCompletedEnd Stage Renal DiseaseItaly
-
Rutgers UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingMetabolic SyndromeUnited States
-
University of RegensburgCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Chr HansenCompleted
-
Tanta UniversityNot yet recruitingNon Alcoholic SteatohepatitisEgypt
-
Boehringer IngelheimNot yet recruiting
-
Unity Health TorontoBoehringer Ingelheim; Canadian Medical and Surgical Knowledge Translation Research... and other collaboratorsCompletedCardiovascular Diseases | Left Ventricular HypertrophyCanada, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedSubstance-Related Disorders | Depression | HIV InfectionsUnited States
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingSTEMI | Left Ventricular Dysfunction | NSTEMI | AMIFrance
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
Tatyana ZubkovaSt. Petersburg State Pavlov Medical University; MDP-CRO, LLCCompletedCOVID-19Russian Federation
-
Appalachian State UniversityRecruitingGastrointestinal Dysfunction | Metabolic DisturbanceUnited States
-
NobelpharmaCompletedCytomegalovirus DiseaseUnited States, Japan
-
Visterra, Inc.Biomedical Advanced Research and Development AuthorityCompletedInfluenzaUnited States, Estonia, South Africa, Bulgaria, Serbia, Ukraine, Latvia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted